Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)

Clinical trial NCT07524114 · RECRUITING

Trial details

NCT number: NCT07524114
Sponsor: University Health Network, Toronto
Status: RECRUITING
Study type: OBSERVATIONAL

Breast Cancer Lung Cancer Melanoma Gynecologic Cancer Genitourinary Cancer Pancreatobiliary Cancer Gastrointestinal Cancer Head and Neck Cancer Rare Cancer Unknown Primary Tumors

Start date: 2026-03-31
Primary completion: 2031-03-31
Enrollment: 7000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.